TY - JOUR AU - Breast Cancer Linkage Consortium PY - 1997 DA - 1997// TI - Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2mutations and sporadic cases. JO - Lancet VL - 349 UR - https://doi.org/10.1016/S0140-6736(96)10109-4 DO - 10.1016/S0140-6736(96)10109-4 ID - Breast Cancer Linkage Consortium1997 ER - TY - JOUR AU - Lakhani, S. R. AU - Jacquemier, J. AU - Sloane, J. P. PY - 1998 DA - 1998// TI - Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2mutations. JO - J Natl Cancer Inst VL - 90 UR - https://doi.org/10.1093/jnci/90.15.1138 DO - 10.1093/jnci/90.15.1138 ID - Lakhani1998 ER - TY - JOUR AU - De Leeuw, W. J. AU - Berx, G. AU - Vos, C. B. PY - 1997 DA - 1997// TI - Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. JO - J Pathol VL - 183 UR - https://doi.org/3.0.CO;2-9 DO - 3.0.CO;2-9 ID - De Leeuw1997 ER - TY - JOUR AU - Berx, G. AU - Cleton-Jansen, A. M. AU - Strumane, K. PY - 1996 DA - 1996// TI - E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. JO - Oncogene VL - 13 ID - Berx1996 ER - TY - JOUR AU - Guilford, P. AU - Hopkins, J. AU - Harraway, J. PY - 1998 DA - 1998// TI - E-cadherin germline mutations in familial gastric cancer. JO - Nature VL - 392 UR - https://doi.org/10.1038/32918 DO - 10.1038/32918 ID - Guilford1998 ER - TY - JOUR AU - Osborne, C. K. PY - 1998 DA - 1998// TI - Steroid hormone receptors in breast cancer management. JO - Breast Cancer Res Treat VL - 51 UR - https://doi.org/10.1023/A:1006132427948 DO - 10.1023/A:1006132427948 ID - Osborne1998 ER - TY - JOUR AU - Henderson, I. C. AU - Patek, A. J. PY - 1998 DA - 1998// TI - The relationship between prognostic and predictive factors in the management of breast cancer. JO - Breast Cancer Res Treat VL - 52 UR - https://doi.org/10.1023/A:1006141703224 DO - 10.1023/A:1006141703224 ID - Henderson1998 ER - TY - JOUR AU - Osin, P. AU - Gusterson, B. A. AU - Philp, E. PY - 1998 DA - 1998// TI - Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers. JO - Eur J Cancer VL - 34 UR - https://doi.org/10.1016/S0959-8049(98)00248-2 DO - 10.1016/S0959-8049(98)00248-2 ID - Osin1998 ER - TY - JOUR AU - Osin, P. AU - Crook, T. AU - Powles, T. AU - Peto, J. AU - Gusterson, B. PY - 1998 DA - 1998// TI - Hormone status of in-situ cancer in BRCA1 and BRCA2mutation carriers [letter]. JO - Lancet VL - 351 UR - https://doi.org/10.1016/S0140-6736(98)24020-7 DO - 10.1016/S0140-6736(98)24020-7 ID - Osin1998 ER - TY - JOUR AU - Johannsson, O. T. AU - Idvall, I. AU - Anderson, C. PY - 1997 DA - 1997// TI - Tumour biological features of BRCA1-induced breast and ovarian cancer. JO - Eur J Cancer VL - 33 UR - https://doi.org/10.1016/S0959-8049(97)89007-7 DO - 10.1016/S0959-8049(97)89007-7 ID - Johannsson1997 ER - TY - JOUR AU - Armes, J. E. AU - Trute, L. AU - White, D. PY - 1999 DA - 1999// TI - Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: a population-based study. JO - Cancer Res VL - 59 ID - Armes1999 ER - TY - JOUR AU - Robson, M. AU - Rajan, P. AU - Rosen, P. P. PY - 1998 DA - 1998// TI - BRCA-associated breast cancer: absence of a characteristic immunophenotype. JO - Cancer Res VL - 58 ID - Robson1998 ER - TY - JOUR AU - Ioakim-Liossi, A. AU - Karakitsos, P. AU - Markopoulos, C. PY - 1997 DA - 1997// TI - Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer. JO - Acta Cytol VL - 41 UR - https://doi.org/10.1159/000332690 DO - 10.1159/000332690 ID - Ioakim-Liossi1997 ER - TY - JOUR AU - Ross, J. S. AU - Fletcher, J. A. PY - 1999 DA - 1999// TI - HER-2/neu (c-erb-B2) gene and protein in breast cancer. JO - Am J Clin Pathol VL - 112(suppl 1) ID - Ross1999 ER - TY - JOUR AU - Rudolph, P. AU - Olsson, H. AU - Bonatz, G. PY - 1999 DA - 1999// TI - Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications. JO - J Pathol VL - 187 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Rudolph1999 ER - TY - JOUR AU - Elledge, R. M. AU - Allred, D. C. PY - 1998 DA - 1998// TI - Prognostic and predictive value of p53 and p21 in breast cancer. JO - Breast Cancer Res Treat VL - 52 UR - https://doi.org/10.1023/A:1006163101948 DO - 10.1023/A:1006163101948 ID - Elledge1998 ER - TY - JOUR AU - Crook, T. AU - Brooks, L. A. AU - Crossland, S. PY - 1998 DA - 1998// TI - p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours. JO - Oncogene VL - 17 UR - https://doi.org/10.1038/sj.onc.1202106 DO - 10.1038/sj.onc.1202106 ID - Crook1998 ER - TY - JOUR AU - Crook, T. AU - Crossland, S. AU - Crompton, M. R. AU - Osin, P. AU - Gusterson, B. A. PY - 1997 DA - 1997// TI - p53 mutations in BRCA1-associated familial breast cancer. JO - Lancet VL - 350 UR - https://doi.org/10.1016/S0140-6736(05)63327-2 DO - 10.1016/S0140-6736(05)63327-2 ID - Crook1997 ER - TY - JOUR AU - Smith, P. D. AU - Crossland, S. AU - Parker, G. PY - 1999 DA - 1999// TI - Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1202565 DO - 10.1038/sj.onc.1202565 ID - Smith1999 ER - TY - JOUR AU - McClelland, R. A. AU - Gee, J. M. AU - O'Sullivan, L. PY - 1999 DA - 1999// TI - p21(WAF1) expression and endocrine response in breast cancer. JO - J Pathol VL - 188 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - McClelland1999 ER - TY - JOUR AU - el-Deiry, W. S. AU - Harper, J. W. AU - O'Connor, P. M. PY - 1994 DA - 1994// TI - WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. JO - Cancer Res VL - 54 ID - el-Deiry1994 ER - TY - JOUR AU - Tan, P. AU - Cady, B. AU - Wanner, M. PY - 1997 DA - 1997// TI - The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. JO - Cancer Res VL - 57 ID - Tan1997 ER - TY - JOUR AU - Mohammed, S. N. AU - Smith, P. AU - Hodgson, S. V. PY - 1998 DA - 1998// TI - Family history and survival in premenopausal breast cancer. JO - Br J Cancer VL - 77 UR - https://doi.org/10.1038/bjc.1998.374 DO - 10.1038/bjc.1998.374 ID - Mohammed1998 ER - TY - JOUR AU - Robson, M. AU - Gilewski, T. AU - Haas, B. PY - 1998 DA - 1998// TI - BRCA-associated breast cancer in young women. JO - J Clin Oncol VL - 16 ID - Robson1998 ER - TY - JOUR AU - Gillett, C. E. AU - Lee, A. H. AU - Millis, R. R. AU - Barnes, D. M. PY - 1998 DA - 1998// TI - Cyclin D1 and associated proteins in mammary ductal carcinoma in situand atypical ductal hyperplasia. JO - J Pathol VL - 184 UR - https://doi.org/3.0.CO;2-G DO - 3.0.CO;2-G ID - Gillett1998 ER - TY - JOUR AU - McMahon, C. AU - Suthiphongchai, T. AU - DiRenzo, J. AU - Ewen, M. E. PY - 1999 DA - 1999// TI - P/CAF associates with cyclin D1 and potentiates its activation of the estrogen receptor. JO - Proc Natl Acad Sci USA VL - 96 UR - https://doi.org/10.1073/pnas.96.10.5382 DO - 10.1073/pnas.96.10.5382 ID - McMahon1999 ER - TY - JOUR AU - Neuman, E. AU - Ladha, M. H. AU - Lin, N. PY - 1997 DA - 1997// TI - Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. JO - Mol Cell Biol VL - 17 UR - https://doi.org/10.1128/MCB.17.9.5338 DO - 10.1128/MCB.17.9.5338 ID - Neuman1997 ER - TY - JOUR AU - Barnes, D. M. AU - Gillett, C. E. PY - 1998 DA - 1998// TI - Cyclin D1 in breast cancer. JO - Breast Cancer Res Treat VL - 52 UR - https://doi.org/10.1023/A:1006103831990 DO - 10.1023/A:1006103831990 ID - Barnes1998 ER - TY - JOUR AU - Duffy, M. J. PY - 1996 DA - 1996// TI - Proteases as prognostic markers in cancer. JO - Clin Cancer Res VL - 2 ID - Duffy1996 ER - TY - JOUR AU - Rochefort, H. AU - Liaudet-Coopman, E. PY - 1999 DA - 1999// TI - Cathepsin D in cancer metastasis: a protease and a ligand. JO - APMIS VL - 107 UR - https://doi.org/10.1111/j.1699-0463.1999.tb01530.x DO - 10.1111/j.1699-0463.1999.tb01530.x ID - Rochefort1999 ER - TY - JOUR AU - Fulco, R. A. AU - Petix, M. AU - Salimbeni, V. AU - Torre, E. A. PY - 1998 DA - 1998// TI - Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2, in breast cancer. JO - Minerva Med VL - 89 ID - Fulco1998 ER - TY - JOUR AU - Gonzalez-Vela, M. C. AU - Garijo, M. F. AU - Fernandez, F. AU - Buelta, L. AU - Val-Bernal, J. F. PY - 1999 DA - 1999// TI - Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. JO - Histopathology VL - 34 UR - https://doi.org/10.1046/j.1365-2559.1999.00548.x DO - 10.1046/j.1365-2559.1999.00548.x ID - Gonzalez-Vela1999 ER -